nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP1A2—Progesterone—uterine cancer	0.158	0.396	CbGbCtD
Betaxolol—CYP2D6—Progesterone—uterine cancer	0.13	0.327	CbGbCtD
Betaxolol—CYP1A2—Etoposide—uterine cancer	0.0706	0.177	CbGbCtD
Betaxolol—CYP2D6—Doxorubicin—uterine cancer	0.0397	0.0997	CbGbCtD
Betaxolol—Chlorphenesin—CYP19A1—uterine cancer	0.00242	1	CrCbGaD
Betaxolol—Renal impairment—Doxorubicin—uterine cancer	0.00053	0.000885	CcSEcCtD
Betaxolol—Malaise—Etoposide—uterine cancer	0.000528	0.000881	CcSEcCtD
Betaxolol—Vertigo—Etoposide—uterine cancer	0.000526	0.000878	CcSEcCtD
Betaxolol—Purpura—Doxorubicin—uterine cancer	0.000524	0.000873	CcSEcCtD
Betaxolol—Body temperature increased—Dactinomycin—uterine cancer	0.000522	0.000871	CcSEcCtD
Betaxolol—Hypoglycaemia—Doxorubicin—uterine cancer	0.000517	0.000863	CcSEcCtD
Betaxolol—Cardiac failure—Doxorubicin—uterine cancer	0.000517	0.000863	CcSEcCtD
Betaxolol—Mood swings—Epirubicin—uterine cancer	0.000517	0.000862	CcSEcCtD
Betaxolol—Loss of consciousness—Etoposide—uterine cancer	0.000515	0.000859	CcSEcCtD
Betaxolol—Lethargy—Doxorubicin—uterine cancer	0.000515	0.000859	CcSEcCtD
Betaxolol—Ataxia—Epirubicin—uterine cancer	0.000513	0.000856	CcSEcCtD
Betaxolol—Cough—Etoposide—uterine cancer	0.000511	0.000853	CcSEcCtD
Betaxolol—Osteoarthritis—Doxorubicin—uterine cancer	0.000505	0.000842	CcSEcCtD
Betaxolol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000503	0.000839	CcSEcCtD
Betaxolol—Chest pain—Etoposide—uterine cancer	0.000499	0.000832	CcSEcCtD
Betaxolol—Affect lability—Doxorubicin—uterine cancer	0.000497	0.000829	CcSEcCtD
Betaxolol—Hypokalaemia—Epirubicin—uterine cancer	0.000496	0.000828	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000495	0.000826	CcSEcCtD
Betaxolol—Discomfort—Etoposide—uterine cancer	0.000493	0.000822	CcSEcCtD
Betaxolol—Breast disorder—Epirubicin—uterine cancer	0.000493	0.000822	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000491	0.000819	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000491	0.000819	CcSEcCtD
Betaxolol—Nasopharyngitis—Epirubicin—uterine cancer	0.000488	0.000814	CcSEcCtD
Betaxolol—Hypersensitivity—Dactinomycin—uterine cancer	0.000487	0.000812	CcSEcCtD
Betaxolol—Confusional state—Etoposide—uterine cancer	0.000482	0.000804	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000481	0.000802	CcSEcCtD
Betaxolol—Mood swings—Doxorubicin—uterine cancer	0.000478	0.000797	CcSEcCtD
Betaxolol—Infection—Etoposide—uterine cancer	0.000475	0.000793	CcSEcCtD
Betaxolol—Ataxia—Doxorubicin—uterine cancer	0.000474	0.000792	CcSEcCtD
Betaxolol—Asthenia—Dactinomycin—uterine cancer	0.000474	0.000791	CcSEcCtD
Betaxolol—Influenza—Epirubicin—uterine cancer	0.000471	0.000786	CcSEcCtD
Betaxolol—Asthma—Epirubicin—uterine cancer	0.000471	0.000786	CcSEcCtD
Betaxolol—Dysphagia—Epirubicin—uterine cancer	0.000471	0.000786	CcSEcCtD
Betaxolol—Thrombocytopenia—Etoposide—uterine cancer	0.000468	0.000781	CcSEcCtD
Betaxolol—Tachycardia—Etoposide—uterine cancer	0.000467	0.000779	CcSEcCtD
Betaxolol—Skin disorder—Etoposide—uterine cancer	0.000464	0.000775	CcSEcCtD
Betaxolol—Hyperhidrosis—Etoposide—uterine cancer	0.000462	0.000771	CcSEcCtD
Betaxolol—Hypokalaemia—Doxorubicin—uterine cancer	0.000459	0.000766	CcSEcCtD
Betaxolol—Angina pectoris—Epirubicin—uterine cancer	0.000459	0.000766	CcSEcCtD
Betaxolol—Breast disorder—Doxorubicin—uterine cancer	0.000456	0.000761	CcSEcCtD
Betaxolol—Anorexia—Etoposide—uterine cancer	0.000456	0.00076	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000454	0.000758	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000454	0.000758	CcSEcCtD
Betaxolol—Bronchitis—Epirubicin—uterine cancer	0.000453	0.000756	CcSEcCtD
Betaxolol—Diarrhoea—Dactinomycin—uterine cancer	0.000452	0.000754	CcSEcCtD
Betaxolol—Nasopharyngitis—Doxorubicin—uterine cancer	0.000451	0.000753	CcSEcCtD
Betaxolol—Hypotension—Etoposide—uterine cancer	0.000447	0.000745	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000445	0.000742	CcSEcCtD
Betaxolol—Dysuria—Epirubicin—uterine cancer	0.000441	0.000735	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000438	0.000731	CcSEcCtD
Betaxolol—Asthma—Doxorubicin—uterine cancer	0.000436	0.000728	CcSEcCtD
Betaxolol—Influenza—Doxorubicin—uterine cancer	0.000436	0.000728	CcSEcCtD
Betaxolol—Dysphagia—Doxorubicin—uterine cancer	0.000436	0.000728	CcSEcCtD
Betaxolol—Paraesthesia—Etoposide—uterine cancer	0.000429	0.000716	CcSEcCtD
Betaxolol—Weight increased—Epirubicin—uterine cancer	0.000429	0.000716	CcSEcCtD
Betaxolol—Weight decreased—Epirubicin—uterine cancer	0.000426	0.000711	CcSEcCtD
Betaxolol—Dyspnoea—Etoposide—uterine cancer	0.000426	0.000711	CcSEcCtD
Betaxolol—Hyperglycaemia—Epirubicin—uterine cancer	0.000425	0.000709	CcSEcCtD
Betaxolol—Angina pectoris—Doxorubicin—uterine cancer	0.000425	0.000709	CcSEcCtD
Betaxolol—Pneumonia—Epirubicin—uterine cancer	0.000423	0.000705	CcSEcCtD
Betaxolol—Infestation NOS—Epirubicin—uterine cancer	0.00042	0.000701	CcSEcCtD
Betaxolol—Infestation—Epirubicin—uterine cancer	0.00042	0.000701	CcSEcCtD
Betaxolol—Vomiting—Dactinomycin—uterine cancer	0.00042	0.000701	CcSEcCtD
Betaxolol—Bronchitis—Doxorubicin—uterine cancer	0.000419	0.0007	CcSEcCtD
Betaxolol—Rash—Dactinomycin—uterine cancer	0.000417	0.000695	CcSEcCtD
Betaxolol—Decreased appetite—Etoposide—uterine cancer	0.000416	0.000693	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Etoposide—uterine cancer	0.000413	0.000689	CcSEcCtD
Betaxolol—Fatigue—Etoposide—uterine cancer	0.000412	0.000688	CcSEcCtD
Betaxolol—Neuropathy peripheral—Epirubicin—uterine cancer	0.000412	0.000687	CcSEcCtD
Betaxolol—Stomatitis—Epirubicin—uterine cancer	0.00041	0.000683	CcSEcCtD
Betaxolol—Pain—Etoposide—uterine cancer	0.000409	0.000682	CcSEcCtD
Betaxolol—Constipation—Etoposide—uterine cancer	0.000409	0.000682	CcSEcCtD
Betaxolol—Conjunctivitis—Epirubicin—uterine cancer	0.000409	0.000682	CcSEcCtD
Betaxolol—Dysuria—Doxorubicin—uterine cancer	0.000408	0.00068	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000405	0.000676	CcSEcCtD
Betaxolol—Sweating—Epirubicin—uterine cancer	0.000403	0.000672	CcSEcCtD
Betaxolol—Weight increased—Doxorubicin—uterine cancer	0.000397	0.000662	CcSEcCtD
Betaxolol—Epistaxis—Epirubicin—uterine cancer	0.000396	0.000661	CcSEcCtD
Betaxolol—Weight decreased—Doxorubicin—uterine cancer	0.000395	0.000658	CcSEcCtD
Betaxolol—Sinusitis—Epirubicin—uterine cancer	0.000394	0.000658	CcSEcCtD
Betaxolol—Feeling abnormal—Etoposide—uterine cancer	0.000394	0.000657	CcSEcCtD
Betaxolol—Hyperglycaemia—Doxorubicin—uterine cancer	0.000393	0.000656	CcSEcCtD
Betaxolol—Nausea—Dactinomycin—uterine cancer	0.000392	0.000655	CcSEcCtD
Betaxolol—Agranulocytosis—Epirubicin—uterine cancer	0.000392	0.000654	CcSEcCtD
Betaxolol—Pneumonia—Doxorubicin—uterine cancer	0.000391	0.000653	CcSEcCtD
Betaxolol—Infestation—Doxorubicin—uterine cancer	0.000389	0.000649	CcSEcCtD
Betaxolol—Infestation NOS—Doxorubicin—uterine cancer	0.000389	0.000649	CcSEcCtD
Betaxolol—Bradycardia—Epirubicin—uterine cancer	0.000384	0.000641	CcSEcCtD
Betaxolol—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000381	0.000636	CcSEcCtD
Betaxolol—Urticaria—Etoposide—uterine cancer	0.00038	0.000634	CcSEcCtD
Betaxolol—Stomatitis—Doxorubicin—uterine cancer	0.000379	0.000632	CcSEcCtD
Betaxolol—Rhinitis—Epirubicin—uterine cancer	0.000378	0.000631	CcSEcCtD
Betaxolol—Body temperature increased—Etoposide—uterine cancer	0.000378	0.000631	CcSEcCtD
Betaxolol—Conjunctivitis—Doxorubicin—uterine cancer	0.000378	0.000631	CcSEcCtD
Betaxolol—Hypoaesthesia—Epirubicin—uterine cancer	0.000375	0.000626	CcSEcCtD
Betaxolol—Pharyngitis—Epirubicin—uterine cancer	0.000374	0.000625	CcSEcCtD
Betaxolol—Sweating—Doxorubicin—uterine cancer	0.000373	0.000622	CcSEcCtD
Betaxolol—Epistaxis—Doxorubicin—uterine cancer	0.000367	0.000612	CcSEcCtD
Betaxolol—Sinusitis—Doxorubicin—uterine cancer	0.000365	0.000609	CcSEcCtD
Betaxolol—Visual impairment—Epirubicin—uterine cancer	0.000364	0.000607	CcSEcCtD
Betaxolol—Agranulocytosis—Doxorubicin—uterine cancer	0.000363	0.000605	CcSEcCtD
Betaxolol—Bradycardia—Doxorubicin—uterine cancer	0.000355	0.000593	CcSEcCtD
Betaxolol—Eye disorder—Epirubicin—uterine cancer	0.000353	0.000588	CcSEcCtD
Betaxolol—Hypersensitivity—Etoposide—uterine cancer	0.000352	0.000588	CcSEcCtD
Betaxolol—Tinnitus—Epirubicin—uterine cancer	0.000352	0.000587	CcSEcCtD
Betaxolol—Cardiac disorder—Epirubicin—uterine cancer	0.00035	0.000584	CcSEcCtD
Betaxolol—Flushing—Epirubicin—uterine cancer	0.00035	0.000584	CcSEcCtD
Betaxolol—Rhinitis—Doxorubicin—uterine cancer	0.00035	0.000584	CcSEcCtD
Betaxolol—Hypoaesthesia—Doxorubicin—uterine cancer	0.000347	0.000579	CcSEcCtD
Betaxolol—Pharyngitis—Doxorubicin—uterine cancer	0.000346	0.000578	CcSEcCtD
Betaxolol—Asthenia—Etoposide—uterine cancer	0.000343	0.000572	CcSEcCtD
Betaxolol—Angiopathy—Epirubicin—uterine cancer	0.000342	0.000571	CcSEcCtD
Betaxolol—Immune system disorder—Epirubicin—uterine cancer	0.000341	0.000569	CcSEcCtD
Betaxolol—Mediastinal disorder—Epirubicin—uterine cancer	0.00034	0.000567	CcSEcCtD
Betaxolol—Chills—Epirubicin—uterine cancer	0.000339	0.000565	CcSEcCtD
Betaxolol—Pruritus—Etoposide—uterine cancer	0.000338	0.000564	CcSEcCtD
Betaxolol—Arrhythmia—Epirubicin—uterine cancer	0.000337	0.000562	CcSEcCtD
Betaxolol—Visual impairment—Doxorubicin—uterine cancer	0.000336	0.000561	CcSEcCtD
Betaxolol—Alopecia—Epirubicin—uterine cancer	0.000333	0.000556	CcSEcCtD
Betaxolol—Mental disorder—Epirubicin—uterine cancer	0.000331	0.000551	CcSEcCtD
Betaxolol—Erythema—Epirubicin—uterine cancer	0.000328	0.000548	CcSEcCtD
Betaxolol—Malnutrition—Epirubicin—uterine cancer	0.000328	0.000548	CcSEcCtD
Betaxolol—Diarrhoea—Etoposide—uterine cancer	0.000327	0.000546	CcSEcCtD
Betaxolol—Eye disorder—Doxorubicin—uterine cancer	0.000326	0.000544	CcSEcCtD
Betaxolol—Tinnitus—Doxorubicin—uterine cancer	0.000325	0.000543	CcSEcCtD
Betaxolol—Flushing—Doxorubicin—uterine cancer	0.000324	0.00054	CcSEcCtD
Betaxolol—Cardiac disorder—Doxorubicin—uterine cancer	0.000324	0.00054	CcSEcCtD
Betaxolol—Tension—Epirubicin—uterine cancer	0.000322	0.000538	CcSEcCtD
Betaxolol—Dysgeusia—Epirubicin—uterine cancer	0.000322	0.000537	CcSEcCtD
Betaxolol—Nervousness—Epirubicin—uterine cancer	0.000319	0.000532	CcSEcCtD
Betaxolol—Angiopathy—Doxorubicin—uterine cancer	0.000317	0.000528	CcSEcCtD
Betaxolol—Dizziness—Etoposide—uterine cancer	0.000316	0.000528	CcSEcCtD
Betaxolol—Muscle spasms—Epirubicin—uterine cancer	0.000316	0.000527	CcSEcCtD
Betaxolol—Immune system disorder—Doxorubicin—uterine cancer	0.000315	0.000526	CcSEcCtD
Betaxolol—Mediastinal disorder—Doxorubicin—uterine cancer	0.000315	0.000525	CcSEcCtD
Betaxolol—Chills—Doxorubicin—uterine cancer	0.000313	0.000523	CcSEcCtD
Betaxolol—Arrhythmia—Doxorubicin—uterine cancer	0.000312	0.00052	CcSEcCtD
Betaxolol—Vision blurred—Epirubicin—uterine cancer	0.00031	0.000516	CcSEcCtD
Betaxolol—Alopecia—Doxorubicin—uterine cancer	0.000308	0.000515	CcSEcCtD
Betaxolol—Mental disorder—Doxorubicin—uterine cancer	0.000306	0.00051	CcSEcCtD
Betaxolol—Ill-defined disorder—Epirubicin—uterine cancer	0.000305	0.000508	CcSEcCtD
Betaxolol—Vomiting—Etoposide—uterine cancer	0.000304	0.000507	CcSEcCtD
Betaxolol—Erythema—Doxorubicin—uterine cancer	0.000304	0.000507	CcSEcCtD
Betaxolol—Malnutrition—Doxorubicin—uterine cancer	0.000304	0.000507	CcSEcCtD
Betaxolol—Anaemia—Epirubicin—uterine cancer	0.000304	0.000506	CcSEcCtD
Betaxolol—Rash—Etoposide—uterine cancer	0.000302	0.000503	CcSEcCtD
Betaxolol—Dermatitis—Etoposide—uterine cancer	0.000301	0.000503	CcSEcCtD
Betaxolol—Headache—Etoposide—uterine cancer	0.0003	0.0005	CcSEcCtD
Betaxolol—Tension—Doxorubicin—uterine cancer	0.000298	0.000497	CcSEcCtD
Betaxolol—Dysgeusia—Doxorubicin—uterine cancer	0.000298	0.000496	CcSEcCtD
Betaxolol—Malaise—Epirubicin—uterine cancer	0.000296	0.000494	CcSEcCtD
Betaxolol—Nervousness—Doxorubicin—uterine cancer	0.000295	0.000492	CcSEcCtD
Betaxolol—Vertigo—Epirubicin—uterine cancer	0.000295	0.000492	CcSEcCtD
Betaxolol—Syncope—Epirubicin—uterine cancer	0.000295	0.000491	CcSEcCtD
Betaxolol—Muscle spasms—Doxorubicin—uterine cancer	0.000292	0.000487	CcSEcCtD
Betaxolol—Palpitations—Epirubicin—uterine cancer	0.00029	0.000484	CcSEcCtD
Betaxolol—Loss of consciousness—Epirubicin—uterine cancer	0.000289	0.000482	CcSEcCtD
Betaxolol—Cough—Epirubicin—uterine cancer	0.000287	0.000478	CcSEcCtD
Betaxolol—Vision blurred—Doxorubicin—uterine cancer	0.000286	0.000478	CcSEcCtD
Betaxolol—Nausea—Etoposide—uterine cancer	0.000284	0.000474	CcSEcCtD
Betaxolol—Ill-defined disorder—Doxorubicin—uterine cancer	0.000282	0.00047	CcSEcCtD
Betaxolol—Anaemia—Doxorubicin—uterine cancer	0.000281	0.000469	CcSEcCtD
Betaxolol—Arthralgia—Epirubicin—uterine cancer	0.00028	0.000466	CcSEcCtD
Betaxolol—Myalgia—Epirubicin—uterine cancer	0.00028	0.000466	CcSEcCtD
Betaxolol—Chest pain—Epirubicin—uterine cancer	0.00028	0.000466	CcSEcCtD
Betaxolol—Anxiety—Epirubicin—uterine cancer	0.000279	0.000465	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000278	0.000463	CcSEcCtD
Betaxolol—Discomfort—Epirubicin—uterine cancer	0.000276	0.000461	CcSEcCtD
Betaxolol—Malaise—Doxorubicin—uterine cancer	0.000274	0.000457	CcSEcCtD
Betaxolol—Dry mouth—Epirubicin—uterine cancer	0.000273	0.000456	CcSEcCtD
Betaxolol—Vertigo—Doxorubicin—uterine cancer	0.000273	0.000455	CcSEcCtD
Betaxolol—Syncope—Doxorubicin—uterine cancer	0.000273	0.000455	CcSEcCtD
Betaxolol—Confusional state—Epirubicin—uterine cancer	0.00027	0.000451	CcSEcCtD
Betaxolol—Palpitations—Doxorubicin—uterine cancer	0.000269	0.000448	CcSEcCtD
Betaxolol—Oedema—Epirubicin—uterine cancer	0.000268	0.000447	CcSEcCtD
Betaxolol—Loss of consciousness—Doxorubicin—uterine cancer	0.000267	0.000446	CcSEcCtD
Betaxolol—Infection—Epirubicin—uterine cancer	0.000266	0.000444	CcSEcCtD
Betaxolol—Cough—Doxorubicin—uterine cancer	0.000265	0.000442	CcSEcCtD
Betaxolol—Shock—Epirubicin—uterine cancer	0.000264	0.00044	CcSEcCtD
Betaxolol—Nervous system disorder—Epirubicin—uterine cancer	0.000263	0.000439	CcSEcCtD
Betaxolol—Thrombocytopenia—Epirubicin—uterine cancer	0.000262	0.000438	CcSEcCtD
Betaxolol—Tachycardia—Epirubicin—uterine cancer	0.000262	0.000436	CcSEcCtD
Betaxolol—Skin disorder—Epirubicin—uterine cancer	0.00026	0.000434	CcSEcCtD
Betaxolol—Hyperhidrosis—Epirubicin—uterine cancer	0.000259	0.000432	CcSEcCtD
Betaxolol—Chest pain—Doxorubicin—uterine cancer	0.000259	0.000432	CcSEcCtD
Betaxolol—Arthralgia—Doxorubicin—uterine cancer	0.000259	0.000432	CcSEcCtD
Betaxolol—Myalgia—Doxorubicin—uterine cancer	0.000259	0.000432	CcSEcCtD
Betaxolol—Anxiety—Doxorubicin—uterine cancer	0.000258	0.00043	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000257	0.000429	CcSEcCtD
Betaxolol—Discomfort—Doxorubicin—uterine cancer	0.000256	0.000426	CcSEcCtD
Betaxolol—Anorexia—Epirubicin—uterine cancer	0.000256	0.000426	CcSEcCtD
Betaxolol—Dry mouth—Doxorubicin—uterine cancer	0.000253	0.000422	CcSEcCtD
Betaxolol—Hypotension—Epirubicin—uterine cancer	0.00025	0.000418	CcSEcCtD
Betaxolol—Confusional state—Doxorubicin—uterine cancer	0.00025	0.000417	CcSEcCtD
Betaxolol—Oedema—Doxorubicin—uterine cancer	0.000248	0.000414	CcSEcCtD
Betaxolol—Infection—Doxorubicin—uterine cancer	0.000246	0.000411	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000244	0.000407	CcSEcCtD
Betaxolol—Shock—Doxorubicin—uterine cancer	0.000244	0.000407	CcSEcCtD
Betaxolol—Nervous system disorder—Doxorubicin—uterine cancer	0.000243	0.000406	CcSEcCtD
Betaxolol—Thrombocytopenia—Doxorubicin—uterine cancer	0.000243	0.000405	CcSEcCtD
Betaxolol—Insomnia—Epirubicin—uterine cancer	0.000242	0.000404	CcSEcCtD
Betaxolol—Tachycardia—Doxorubicin—uterine cancer	0.000242	0.000404	CcSEcCtD
Betaxolol—Skin disorder—Doxorubicin—uterine cancer	0.000241	0.000402	CcSEcCtD
Betaxolol—Paraesthesia—Epirubicin—uterine cancer	0.000241	0.000402	CcSEcCtD
Betaxolol—Hyperhidrosis—Doxorubicin—uterine cancer	0.00024	0.0004	CcSEcCtD
Betaxolol—Dyspnoea—Epirubicin—uterine cancer	0.000239	0.000399	CcSEcCtD
Betaxolol—Anorexia—Doxorubicin—uterine cancer	0.000236	0.000394	CcSEcCtD
Betaxolol—Dyspepsia—Epirubicin—uterine cancer	0.000236	0.000394	CcSEcCtD
Betaxolol—Decreased appetite—Epirubicin—uterine cancer	0.000233	0.000389	CcSEcCtD
Betaxolol—Hypotension—Doxorubicin—uterine cancer	0.000232	0.000387	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000231	0.000386	CcSEcCtD
Betaxolol—Fatigue—Epirubicin—uterine cancer	0.000231	0.000386	CcSEcCtD
Betaxolol—Constipation—Epirubicin—uterine cancer	0.000229	0.000382	CcSEcCtD
Betaxolol—Pain—Epirubicin—uterine cancer	0.000229	0.000382	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000226	0.000377	CcSEcCtD
Betaxolol—Insomnia—Doxorubicin—uterine cancer	0.000224	0.000374	CcSEcCtD
Betaxolol—Paraesthesia—Doxorubicin—uterine cancer	0.000223	0.000372	CcSEcCtD
Betaxolol—Dyspnoea—Doxorubicin—uterine cancer	0.000221	0.000369	CcSEcCtD
Betaxolol—Feeling abnormal—Epirubicin—uterine cancer	0.000221	0.000368	CcSEcCtD
Betaxolol—Dyspepsia—Doxorubicin—uterine cancer	0.000218	0.000364	CcSEcCtD
Betaxolol—Decreased appetite—Doxorubicin—uterine cancer	0.000216	0.00036	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000214	0.000357	CcSEcCtD
Betaxolol—Fatigue—Doxorubicin—uterine cancer	0.000214	0.000357	CcSEcCtD
Betaxolol—Urticaria—Epirubicin—uterine cancer	0.000213	0.000355	CcSEcCtD
Betaxolol—Pain—Doxorubicin—uterine cancer	0.000212	0.000354	CcSEcCtD
Betaxolol—Constipation—Doxorubicin—uterine cancer	0.000212	0.000354	CcSEcCtD
Betaxolol—Body temperature increased—Epirubicin—uterine cancer	0.000212	0.000353	CcSEcCtD
Betaxolol—Feeling abnormal—Doxorubicin—uterine cancer	0.000204	0.000341	CcSEcCtD
Betaxolol—Hypersensitivity—Epirubicin—uterine cancer	0.000197	0.000329	CcSEcCtD
Betaxolol—Urticaria—Doxorubicin—uterine cancer	0.000197	0.000329	CcSEcCtD
Betaxolol—Body temperature increased—Doxorubicin—uterine cancer	0.000196	0.000327	CcSEcCtD
Betaxolol—Asthenia—Epirubicin—uterine cancer	0.000192	0.000321	CcSEcCtD
Betaxolol—Pruritus—Epirubicin—uterine cancer	0.00019	0.000316	CcSEcCtD
Betaxolol—Diarrhoea—Epirubicin—uterine cancer	0.000183	0.000306	CcSEcCtD
Betaxolol—Hypersensitivity—Doxorubicin—uterine cancer	0.000183	0.000305	CcSEcCtD
Betaxolol—Asthenia—Doxorubicin—uterine cancer	0.000178	0.000297	CcSEcCtD
Betaxolol—Dizziness—Epirubicin—uterine cancer	0.000177	0.000296	CcSEcCtD
Betaxolol—Pruritus—Doxorubicin—uterine cancer	0.000175	0.000293	CcSEcCtD
Betaxolol—Vomiting—Epirubicin—uterine cancer	0.00017	0.000284	CcSEcCtD
Betaxolol—Diarrhoea—Doxorubicin—uterine cancer	0.00017	0.000283	CcSEcCtD
Betaxolol—Rash—Epirubicin—uterine cancer	0.000169	0.000282	CcSEcCtD
Betaxolol—Dermatitis—Epirubicin—uterine cancer	0.000169	0.000282	CcSEcCtD
Betaxolol—Headache—Epirubicin—uterine cancer	0.000168	0.00028	CcSEcCtD
Betaxolol—Dizziness—Doxorubicin—uterine cancer	0.000164	0.000274	CcSEcCtD
Betaxolol—Nausea—Epirubicin—uterine cancer	0.000159	0.000266	CcSEcCtD
Betaxolol—Vomiting—Doxorubicin—uterine cancer	0.000158	0.000263	CcSEcCtD
Betaxolol—Rash—Doxorubicin—uterine cancer	0.000156	0.000261	CcSEcCtD
Betaxolol—Dermatitis—Doxorubicin—uterine cancer	0.000156	0.000261	CcSEcCtD
Betaxolol—Headache—Doxorubicin—uterine cancer	0.000155	0.000259	CcSEcCtD
Betaxolol—Nausea—Doxorubicin—uterine cancer	0.000147	0.000246	CcSEcCtD
